Molina Healthcare (MOH) director reports 317-share stock award under 2025 plan

Q: What insider transaction did Molina Healthcare (MOH) disclose in this Form 4?

The filing reports that a director of Molina Healthcare, Inc. received a grant of 317 shares of common stock on January 1, 2026 as part of his compensation for serving on the board under the company’s 2025 Equity Incentive Plan .

Q: How was the number of shares in the Molina Healthcare (MOH) director grant calculated?

The grant reflects one quarter of a $220,000 annual equity award, or $55,000 this quarter, divided by the $173.54 closing price of Molina Healthcare common stock on December 31, 2025 , resulting in 317 shares .

Q: Why did Molina Healthcare (MOH) use the December 31, 2025 price for this director stock grant?

The grant date of January 1, 2026 was a non-trading day, so the number of shares was based on the December 31, 2025 closing price of $173.54 , as explained in the filing.

Q: In whose name are the reported Molina Healthcare (MOH) shares held?

The shares are held by the Dale B. Wolf Revocable Trust , and Dale B. Wolf is identified as the sole trustee, giving him indirect beneficial ownership of the shares.

Q: Is this Molina Healthcare (MOH) Form 4 transaction a stock sale or a compensation grant?

The transaction is described as a grant of stock under the 2025 Equity Incentive Plan in connection with the reporting person’s services as a Director , not as an open-market stock sale or purchase.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Molina Healthcare director reports routine stock grant

A director of Molina Healthcare, Inc. reported receiving 317 shares of common stock on January 1, 2026 under the company’s 2025 Equity Incentive Plan for board service. The quarterly grant represents one quarter of an annual equity award valued at $220,000, with this quarter’s $55,000 portion calculated using the $173.54 closing price of Molina Healthcare common stock on December 31, 2025, because January 1 was a non-trading day.

After this award, the reporting person beneficially owns 14,991 shares of Molina Healthcare common stock, held indirectly through the Dale B. Wolf Revocable Trust, for which he serves as sole trustee. The filing describes this as compensation for services as a director rather than an open-market purchase or sale.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider WOLF DALE B

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	317	$173.54	$55K

Holdings After Transaction: Common Stock — 14,991 shares (Indirect, Held by Trust)

Footnotes (1)

Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director. The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of January 1, 2026, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on December 31, 2025, of $173.54. Thus, the grant this quarter for services as a Director is for 317 shares of the Issuer's common stock. Represents the closing price of the Issuer's common stock on December 31, 2025. Shares are held by Dale B. Wolf Revocable Trust, of which Dale B. Wolf is the sole trustee.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

01/02/2026 - 04:51 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

WOLF DALE B

(Last)

(First)

(Middle)

2180 HARVARD STREET

SUITE 400

(Street)

SACRAMENTO

95815

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
MOLINA HEALTHCARE, INC. [ MOH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/01/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	01/01/2026		A⁽¹⁾		317⁽²⁾	A	$173.54⁽³⁾	14,991	I	Held by Trust⁽⁴⁾

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

2. The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of January 1, 2026, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on December 31, 2025, of $173.54. Thus, the grant this quarter for services as a Director is for 317 shares of the Issuer's common stock.

3. Represents the closing price of the Issuer's common stock on December 31, 2025.

4. Shares are held by Dale B. Wolf Revocable Trust, of which Dale B. Wolf is the sole trustee.

Remarks:

	Jeff D. Barlow, by power of attorney for Dale B. Wolf.	01/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Molina Healthcare (MOH) disclose in this Form 4?

The filing reports that a director of Molina Healthcare, Inc. received a grant of 317 shares of common stock on January 1, 2026 as part of his compensation for serving on the board under the company’s 2025 Equity Incentive Plan.

How was the number of shares in the Molina Healthcare (MOH) director grant calculated?

The grant reflects one quarter of a $220,000 annual equity award, or $55,000 this quarter, divided by the $173.54 closing price of Molina Healthcare common stock on December 31, 2025, resulting in 317 shares.

Why did Molina Healthcare (MOH) use the December 31, 2025 price for this director stock grant?

The grant date of January 1, 2026 was a non-trading day, so the number of shares was based on the December 31, 2025 closing price of $173.54, as explained in the filing.

How many Molina Healthcare (MOH) shares does the reporting person own after this transaction?

Following the reported grant, the director beneficially owns 14,991 shares of Molina Healthcare common stock, held indirectly through the Dale B. Wolf Revocable Trust.

In whose name are the reported Molina Healthcare (MOH) shares held?

The shares are held by the Dale B. Wolf Revocable Trust, and Dale B. Wolf is identified as the sole trustee, giving him indirect beneficial ownership of the shares.

Is this Molina Healthcare (MOH) Form 4 transaction a stock sale or a compensation grant?

The transaction is described as a grant of stock under the 2025 Equity Incentive Plan in connection with the reporting person’s services as a Director, not as an open-market stock sale or purchase.